• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Journal of pharmacy technology: jPT : official publication of the Association of Pharmacy Technicians >Identifying Missed Opportunities for the Pneumococcal Conjugate Vaccine (PCV13)
【24h】

Identifying Missed Opportunities for the Pneumococcal Conjugate Vaccine (PCV13)

机译：识别肺炎球菌缀合物疫苗的错过机会（PCV13）

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The recommendation for the pneumococcal conjugate vaccine (PCV13) in adults 65 years and older is recent, and the dosing schedule of PCV13 and the pneumococcal polysaccharide vaccine (PPSV23) can be complex in this population. Objective: The authors assessed the rate of PCV13 immunization in patients 65 years of age and older and identified barriers that contributed to missed opportunities for PCV13. Methods: This retrospective review evaluated outpatient Veterans age 65 years or older who did not receive PCV13 at a scheduled primary care appointment despite an electronic reminder. Investigators recorded any documented reason for the patient not receiving PCV13. Results: The rate of PCV13 immunizations administered during the primary care visit study period was 37% (89 of 239 PCV13 eligible patients). Of the 150 patients identified who did not receive PCV13, 92% were not offered the vaccine, 6.7% declined vaccination, and 0.7% reported an allergy to vaccination. Electronic immunization records revealed that 48 of the 150 patients who did not receive PCV13 at their clinic appointment did receive PCV13 later the same year. Most patients received PCV13 in influenza vaccine season on the same day as receiving the influenza vaccine. Conclusion: The main barrier identified was not offering the vaccination during primary care visits. Pneumococcal vaccine administration was delayed until the influenza vaccine season in a significant portion of patients. This unexpected finding represents a target for education: ensuring health care professionals are reminded that PCV13 is not a seasonal vaccine like the influenza vaccine, but should be offered throughout the year.
机译：背景：对65岁及以上成年人使用肺炎球菌结合疫苗（PCV13）的建议是最近才提出的，在这一人群中，PCV13和肺炎球菌多糖疫苗（PPSV23）的给药计划可能很复杂。目的：作者评估了65岁及以上患者的PCV13免疫接种率，并确定了导致错过PCV13机会的障碍。方法：这项回顾性研究评估了65岁或65岁以上的门诊退伍军人，他们在计划的初级保健预约中没有接受PCV13，尽管有电子提醒。调查人员记录了患者未接受PCV13治疗的任何书面原因。结果：在初级保健访问研究期间，PCV13免疫接种率为37%（239例符合条件的PCV13患者中有89例）。在确定的150名未接种PCV13的患者中，92%未接种疫苗，6.7%拒绝接种，0.7%报告接种过敏。电子免疫记录显示，在门诊预约时未接受PCV13治疗的150名患者中，有48人在同年晚些时候接受了PCV13治疗。大多数患者在流感疫苗季节与接种流感疫苗的同一天接种PCV13。结论：确定的主要障碍是在初级保健访问期间不提供疫苗接种。在很大一部分患者中，肺炎球菌疫苗接种被推迟到流感疫苗接种季节。这一意外发现代表了一个教育目标：确保卫生保健专业人员被提醒，PCV13不是流感疫苗那样的季节性疫苗，而是应该全年提供。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号